Dermatitis News

The efficacy of tapinarof cream 1% has validated the aryl hydrocarbon receptor as a therapeutic target for the treatment of atopic dermatitis, according to a study.

WASHINGTON — Atopic dermatitis can be predicted in children aged as young as 6 months with skin microbiome and metabolome signatures, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Ruxolitinib was efficacious and well tolerated in pediatric patients with mild to moderate atopic dermatitis, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Patients with moderate to severe atopic dermatitis treated with lebrikizumab maintained improvements in patient-reported outcomes, according to a poster presented here.

WASHINGTON — Patients with atopic dermatitis may have better outcomes when using liquid synthetic detergents, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Topical ruxolitinib cream significantly reduced skin manifestations caused by cutaneous graft-versus-host disease compared with vehicle cream, results from a randomized phase 2 study showed.

WASHINGTON — Among children with atopic dermatitis, low non-lesional skin filaggrin expression during early ages predicted future asthma, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

WASHINGTON — Treatment with 1% tapinarof cream led to symptom improvements for most patients with atopic dermatitis, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Data showed that not all patients with chronic inflammatory skin diseases undergo pretreatment testing before initiating systemic immunomodulatory therapies, despite current guidelines, according to a study.

MIAMI BEACH, Fla. — Zabalafin, a nonsteroidal topical, demonstrated efficacy in reducing inflammation and bacteria on the skin of children and adults with atopic dermatitis, according to interim data presented in a poster at Masters of Pediatric Dermatology.